Vasculitis & polymyalgia rheumatica

Assessment of damage in Takayasu’s arteritis

Rheumatology (Oxford)Published Prospective observational cohort study

Authors' conclusion

Damage is present in >80% of patients with TAK even with recent diagnosis and >40% of patients accrue new, mainly disease-specific damage.

Study context

Population
Patients with TAK in a multicentre prospective observational study (92% female, 81% Caucasian; median disease duration 2.6 years)84% had follow-up
Participants
236 patients
Outcome
Damage assessed by VDI and LVVID, and clinical characteristics associated with damage
Methodological detailsmulticentre, standardized damage assessment every 6 months (Vasculitis Damage Index (VDI) and Large-Vessel Vasculitis Index of Damage (LVVID))
  • Multicentre
  • Standardized damage assessment every 6 months (VDI and LVVID)

Main finding

As reported in the abstract

Items of damage present
Any damage, VDI
89%
Any damage, LVVID
87%
Peripheral vascular damage, VDI
76%
Peripheral vascular damage, LVVID
74%
Cardiac damage, VDI
40%
Cardiac damage, LVVID
45%

Observational data: associations, not effects.

Further findings

New damage during follow-up · median follow-up 4.1 (1.9, 7.5) years

Patients with new damage
42%
Major vessel stenosis/arterial occlusion
8%
Limb claudication
6%
Hypertension
7%
Aortic aneurysm
4%
Bypass surgery
4%
Disease-specific damage share of new items
>90%

Factors associated with new damage

Higher proportion of patients without new damage on MTX
P < 0.05
Older age, relapse and longer follow-up associated with new damage items
History of relapse associated with new damage in entire cohort; older age at diagnosis in recently diagnosed

New damage in patients diagnosed within 180 days of enrolment (subgroup, n=48)

New damage, VDI
31%
New damage, LVVID
52%

Original publication

Assessment of damage in Takayasu’s arteritis. Rheumatology (Oxford). Published 17 June 2024. doi:10.1093/rheumatology/keae333

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.